This stimulation that generated bidirectional HERV transcripts formed dsRNA detectable by cellular PRRs, and caused type I and type III IFN responses in colorectal cancer cells, reducing the antitumor activity of DNA methyltransferase inhibitors (Vitiello et al., 2021). The gene discussed is IFNA1; the disease is colorectal cancer.